J.J. Cornelissen

913 citations

32 papers · 657 indexed · h-index 12

Hematology top 2%
Immunology top 10%
Oncology
Public Health, Environmental and Occupational Health
Molecular Biology

Co-authors: Leo F. Verdonck A Schattenberg HM Lokhorst L. L. M. Thomas M. Rozenberg-Arska A W Dekker A. W. Dekker M. Schoester
Topics: Hematopoietic Stem Cell Transplantation (9 papers)Acute Myeloid Leukemia Research (7 papers)Acute Lymphoblastic Leukemia research (6 papers)
Cited by: Hematology Transplantation Immunology
Journals: Journal of Clinical Oncology Blood Clinical Infectious Diseases
Partner nations: Netherlands France Belgium

In The Last Decade

J.J. Cornelissen

30 papers receiving 627 citations

Peers

Countries citing papers authored by J.J. Cornelissen

Since Specialization

Citations

This map shows the geographic impact of J.J. Cornelissen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.J. Cornelissen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.J. Cornelissen more than expected).

Fields of papers citing papers by J.J. Cornelissen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.J. Cornelissen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.J. Cornelissen. The network helps show where J.J. Cornelissen may publish in the future.

Co-authorship network of co-authors of J.J. Cornelissen

This figure shows the co-authorship network connecting the top 25 collaborators of J.J. Cornelissen. A scholar is included among the top collaborators of J.J. Cornelissen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.J. Cornelissen. J.J. Cornelissen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GRAFT VERSUS LEUKEMIA EFFECT OF ALLOGENEIC STEM CELL TRANSPLANTATION AND MINIMAL RESIDUAL DISEASE IN PATIENTS WITH AML IN FIRST COMPLETE REMISSION 2017 ·Pure Amsterdam UMC ·Jurjen Versluis,(unknown),Wendelien Zeijlemaker,Jakob Passweg,Carlos Graux,Markus G. Manz,(unknown),Bart J. Biemond,(unknown),Marinus van Marwijk Kooy,(unknown),Thomas Pabst,Bob Löwenberg,Mojca Jongen‐Lavrencic,Gerrit‐Jan Schuurhuis,G.J. Ossenkoppele,J.J. Cornelissen	2
2	Impact of dose intensity on unrelated cord blood transplantation outcomes in adults patients with acute leukemia: A Report from Eurocord, the ALWP and the Cord Blood Committee of the CTIWP of the EBMT 2016 ·Bone Marrow Transplantation ·F Baron,Annalisa Ruggeri,Eric Beohou,Myriam Labopin,Guillermo Sanz,Nöel Milpied,M Michallet,Gèrard Socié,Didier Blaise,Jorge Sierra,J.J. Cornelissen,Mohamad Mohty,Christoph Schmid,Sebastian Giebel,Norbert Claude Gorin,Jordi Esteve,Fabio Ciceri,Bipin N. Savani,Éliane Gluckman,Arnon Nagler	1
3	In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available? 2015 ·Bone Marrow Transplantation ·Régis Peffault de Latour,Myriam Labopin,J.J. Cornelissen,S. Vigouroux,Charles Craddock,Didier Blaise,(unknown),Lars L. Vindeløv,J Maertens,Patrice Chevallier,Nathalie Fegueux,G. Socié,Jean‐Yves Cahn,Evan J. Petersen,Harry C. Schouten,Bruno Lioure,Nigel H. Russell,(unknown),Fabio Ciceri,Arnon Nagler,Mohamad Mohty,(unknown)	11
4	Translating in vitro prediction of cytotoxic T cell alloreactivity to hematopoietic stem cell transplantation outcome 2014 ·Transplant Immunology ·(unknown),(unknown),Peter A. von dem Borne,Jürgen Kuball,Marc Bierings,J.J. Cornelissen,(unknown),Bronno van der Holt,J. J. van Rood,Machteld Oudshoorn,Frans H.J. Claas	12
5	The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT 2012 ·Bone Marrow Transplantation ·Sebastian Giebel,Myriam Labopin,Mohamad Mohty,G J Mufti,Dietger Niederwieser,J.J. Cornelissen,Jeroen J. W. M. Janssen,Nöel Milpied,Lars L. Vindeløv,Eefke Petersen,R Arnold,Andrea Bacigalupo,Didier Blaise,Charles Craddock,A Nagler,Francesco Frassoni,Maria Saduś‐Wojciechowska,Vanderson Rocha	22
6	Impact of Cytogenetics Risk on Outcome After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) From an HLA Identical Sibling for Patients With Acute Myeloid Leukemia (AML) in First Complete Remission (CR1) 2009 ·Biology of Blood and Marrow Transplantation ·Mohamad Mohty,Myriam Labopin,Nöel Milpied,J.J. Cornelissen,Didier Blaise,Eefke Petersen,Niklas Theorin,Hakan Göker,G. Socié,(unknown)	1
7	Impact of the intensity of conditioning regimen in 144 patients with follicular lymphoma (FL) receiving a matched unrelated donor stem cell transplant (MUD-SCT): An analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (LWP-EBMT) 2008 ·Journal of Clinical Oncology ·Anna Sureda,Irit Avivi,(unknown),Johan Maertens,D Niederwieser,G J Mufti,Jürgen Finke,A Schattenberg,J.J. Cornelissen,Hervé Tilly,Silvia Montoto	3
8	Allogeneic Stem Cell Transplantation (Allo-SCT) in the Management of Advanced Waldenstrom’s Macroglobulinemia (WM). 2007 ·Blood ·Charalampia Kyriakou,(unknown),Anna Sureda,G. Taghipour,J.J. Cornelissen,R. Willemze,Gèrard Socié,H. Greinix,Joachim Kienast,Rose Marie Hamladji,M Kazmi,Peter Jacob,Norbert Schmitz	4
9	How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more! 2005 ·Bone Marrow Transplantation ·Martin B.A. Heemskerk,Suzanna M. van Walraven,J.J. Cornelissen,R M Y Barge,Robbert G. M. Bredius,R. Maarten Egeler,(unknown),Tom Révész,K. Sintnicolaas,N. M. Wulffraat,Albertine E. Donker,Peter M. Hoogerbrugge,J. J. van Rood,Frans H.J. Claas,Machteld Oudshoorn	74
10	[A patient with sinus thrombosis associated with paroxysmal nocturnal hemoglobinuria]. 2005 ·PubMed ·(unknown),M. C. Kappers‐Klunne,J.J. Cornelissen,Martin J. van den Bent,Walter Taal	2
11	Postoperative Schmerztherapie bei minimal-invasiver direkter koronararterieller Bypass-Chirurgie (MIDCAB) 2002 ·Der Anaesthesist ·(unknown),Götz Geldner,J.J. Cornelissen,(unknown),Frank Möller,Jochen Cremer,Hinnerk Wulf	6
12	No impact of high‐dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission 2000 ·British Journal of Haematology ·Jean‐Yves Cahn,Myriam Labopin,Jorge Sierra,Didier Blaise,Josy Reiffers,(unknown),Lothar Bergmann,Giuseppe Visani,J.J. Cornelissen,(unknown),Alberto Bosi,Francesco Frassoni,Norbert Claude Gorin,(unknown)	51
13	Management of psychiatric adverse events with immunotherapy with interferon-alfa 1999 ·Acta Neuropsychiatrica ·Arthur R. Van Gool,Wim H.J. Kruit,J.J. Cornelissen,L Berk,A.M.M. Eggermont,M. Bannink	8
14	Discontinuation of Intravenous Antibiotic Therapy During Persistent Neutropenia in Patients Receiving Prophylaxis with Oral Ciprofloxacin 1995 ·Clinical Infectious Diseases ·J.J. Cornelissen,M. Rozenberg-Arska,A W Dekker	26
15	MDR-1 expression and response to vincristine, doxorubicin, and dexamethasone chemotherapy in multiple myeloma refractory to alkylating agents. 1994 ·Journal of Clinical Oncology ·J.J. Cornelissen,Pieter Sonneveld,M. Schoester,(unknown),H K Nieuwenhuis,A. W. Dekker,H M Lokhorst	65
16	Protection against Lethal Endotoxemia by Anti-Lipid A Murine Monoclonal Antibodies: Comparison of Efficacy with That of Human Anti-Lipid A Monoclonal Antibody HA-1A 1993 ·The Journal of Infectious Diseases ·J.J. Cornelissen,(unknown),Ale Algra,Barry Benaissa-Trouw,(unknown),C. A. Kraaijeveld,J. Verhoef	13
17	Reply 1993 ·The Journal of Infectious Diseases ·J.J. Cornelissen,(unknown),(unknown),(unknown),J. F. P. Schellekens,C. A. Kraaijeveld,J. Verhoef	1
18	Inhibition by lipid A-specific monoclonal antibodies of priming of human polymorphonuclear leucocytes by endotoxin 1991 ·Journal of Medical Microbiology ·J.J. Cornelissen,Christoph Kessel,E. Brouwer,C. A. Kraaijeveld,J. Verhoef	10
19	Discrimination by rabbit anti-idiotypic antibodies of two murine IgM monoclonal antibodies directed against lipid A 1990 ·Journal of Immunological Methods ·J.J. Cornelissen,(unknown),J. F. P. Schellekens,Ruurd Torensma,M. Rozenberg-Arska,C. A. Kraaijeveld,J. Verhoef	4
20	Plasma exchange in rhabdomyolysis 1989 ·Intensive Care Medicine ·J.J. Cornelissen,(unknown),H. J. T. M. Haarman,R. H. W. M. Derksen	12

About J.J. Cornelissen

J.J. Cornelissen is a scholar working on Hematology, Microbiology and Transplantation, having authored 32 papers that have together received 657 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (9 papers), Acute Myeloid Leukemia Research (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). The work is most often cited by research in Hematology (410 citations), Transplantation (40 citations) and Immunology (222 citations). J.J. Cornelissen has collaborated with scholars based in Netherlands, France and Belgium. Frequent co-authors include Leo F. Verdonck, A Schattenberg, HM Lokhorst, L. L. M. Thomas, M. Rozenberg-Arska, A W Dekker, A. W. Dekker, M. Schoester, Pieter Sonneveld and J. Verhoef. Their work appears in journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact